PPLPHARMA

Piramal Pharma Ltd is a global pharma company operating in CDMO (contract manufacturing), hospital generics, and consumer healthcare, with manufacturing facilities in India, the US, and Europe. 📉 Current Price Snapshot Current price: around ₹150–₹160 range (2026 recent trading) 52-week high: ₹240 52-week low: ₹147 Market cap: ₹20,000–23,000 crore 1-year return: 23% to -26% (weak performance) ➡️ Stock has corrected significantly from highs. 1️⃣ Revenue & Profit Revenue (TTM): ~₹8,800–₹8,900 crore Net profit: loss ~₹164 crore EBITDA: ₹950 crore 📌 Interpretation Revenue stable Profitability weak due to CDMO slowdown and costs. Recent quarter: Q3 FY26 loss ₹136 crore Revenue ₹2,140 crore (-3% YoY)